Affordable Access

deepdyve-link
Publisher Website

Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease.

Authors
  • Pontali, Emanuele1
  • Volpi, Stefano2
  • Antonucci, Giancarlo1
  • Castellaneta, Marco1
  • Buzzi, Davide1
  • Tricerri, Francesca1
  • Angelelli, Alessia2
  • Caorsi, Roberta2
  • Feasi, Marcello1
  • Calautti, Francesca1
  • Castagnola, Elio2
  • Rollandi, Gian Andrea1
  • Ravelli, Angelo2
  • Cassola, Giovanni1
  • Gattorno, Marco3
  • 1 Ente Ospedaliero Ospedale Galliera, Genova, Italy. , (Italy)
  • 2 IRCCS G. Gaslini, Genova, Italy. , (Italy)
  • 3 IRCCS G. Gaslini, Genova, Italy. Electronic address: [email protected] , (Italy)
Type
Published Article
Journal
The Journal of allergy and clinical immunology
Publication Date
Jul 01, 2020
Volume
146
Issue
1
Pages
213–215
Identifiers
DOI: 10.1016/j.jaci.2020.05.002
PMID: 32437739
Source
Medline
Language
English
License
Unknown
Report this publication

Statistics

Seen <100 times